Suppr超能文献

2011 - 2020年美国丙型肝炎病毒基因型的分布及炎症潜力

Distribution and inflammatory potential of hepatitis C virus genotypes in the United States, 2011-2020.

作者信息

Gnanapandithan Karthik, Stemboroski Lauren, Johnston Abbey, Ghali Maged P

机构信息

Division of Hospital Internal Medicine Mayo Clinic Jacksonville Florida USA.

Division of Gastroenterology and Hepatology University of Florida Jacksonville Florida USA.

出版信息

JGH Open. 2024 Nov 4;8(11):e70049. doi: 10.1002/jgh3.70049. eCollection 2024 Nov.

Abstract

HCV is marked by genetic diversity that impacts disease progression and outcome. Using the NHANES data from 266 HCV-infected adults (2011-2020), this study infers that genotype 1a is the most prevalent (60.2%). Genotype 3 was associated with higher transaminase levels, though not statistically significant. These findings suggest a more aggressive phenotype for genotype 3. Despite pan-genotypic treatment guidelines, this underscores the importance of continued HCV genotype surveillance and consideration for genotype-specific treatment and monitoring strategies.

摘要

丙型肝炎病毒(HCV)具有基因多样性,这会影响疾病的进展和结局。本研究利用2011年至2020年266名HCV感染成年人的美国国家健康与营养检查调查(NHANES)数据推断,1a基因型最为普遍(60.2%)。3基因型与较高的转氨酶水平相关,尽管无统计学意义。这些发现表明3基因型具有更强的侵袭性表型。尽管有泛基因型治疗指南,但这凸显了持续进行HCV基因型监测以及考虑采用基因型特异性治疗和监测策略的重要性。

相似文献

1
Distribution and inflammatory potential of hepatitis C virus genotypes in the United States, 2011-2020.
JGH Open. 2024 Nov 4;8(11):e70049. doi: 10.1002/jgh3.70049. eCollection 2024 Nov.
3
NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements. 2002;19(3):1-46.
9
Hepatitis C virus genotypes in patients with chronic hepatitis C infection in southern Iran from 2016 to 2019.
Microbiol Immunol. 2020 Nov;64(11):762-767. doi: 10.1111/1348-0421.12845. Epub 2020 Oct 7.
10
Epidemiology and Genotype Distribution of Hepatitis C Virus in Russia.
Pathogens. 2022 Dec 6;11(12):1482. doi: 10.3390/pathogens11121482.

本文引用的文献

4
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.
Lancet Gastroenterol Hepatol. 2022 Apr;7(4):307-317. doi: 10.1016/S2468-1253(21)00397-6. Epub 2022 Jan 10.
5
Real-world experiences with direct-acting antiviral agents for chronic hepatitis C treatment.
J Viral Hepat. 2020 Feb;27(2):195-204. doi: 10.1111/jvh.13218. Epub 2019 Nov 11.
6
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.
Hepatology. 2019 Mar;69(3):1020-1031. doi: 10.1002/hep.30297. Epub 2018 Nov 6.
8
Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.
J Infect Dis. 2016 Oct 15;214(8):1164-70. doi: 10.1093/infdis/jiw332. Epub 2016 Aug 2.
9
Global distribution and prevalence of hepatitis C virus genotypes.
Hepatology. 2015 Jan;61(1):77-87. doi: 10.1002/hep.27259. Epub 2014 Jul 28.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验